$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023024927 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$5.504M	$4.104M	$24.39M
YoY Change	-36.03%	-51.45%	-36.38%
Cost Of Revenue	$5.573M	$3.943M	$21.14M
YoY Change	-8.9%	-61.63%	-41.3%
Gross Profit	-$69.47K	$160.9K	$3.254M
YoY Change	-102.79%	-108.83%	39.72%
Gross Profit Margin	-1.26%	3.92%	13.34%
Selling, General & Admin	$1.876M	$3.970M	$10.44M
YoY Change	103.19%	1042.42%	3072.12%
% of Gross Profit		2466.64%	320.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$92.19K	$134.6K	$410.3K
YoY Change	-12.05%	-7.65%	2.9%
% of Gross Profit		83.61%	12.61%
Operating Expenses	$3.191M	$3.980M	$10.48M
YoY Change	54.32%	1045.35%	26.13%
Operating Profit	-$3.260M	-$3.819M	-$7.230M
YoY Change	-878.26%	75.92%	20.84%
Interest Expense	$287.4K	-$121.2K	-$262.4K
YoY Change	488.29%	-872.04%	-568.94%
% of Operating Profit
Other Income/Expense, Net	-$259.4K	-$59.94K	$140.7K
YoY Change	-413.11%	-5404.42%	88.95%
Pretax Income	-$3.519M	-$4.025M	-$7.089M
YoY Change	-801.46%	86.03%	19.99%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$3.519M	-$3.733M	-$8.319M
YoY Change	390.74%	8.94%	-23.2%
Net Earnings / Revenue	-63.94%	-90.96%	-34.1%
Basic Earnings Per Share	-$0.25		-$0.62
Diluted Earnings Per Share	-$0.25	-$0.27	-$0.62
COMMON SHARES
Basic Shares Outstanding	14.31M shares	12.05M shares	13.33M shares
Diluted Shares Outstanding	14.00M shares		13.33M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.453M	$582.8K	$582.8K
YoY Change	-88.95%	-95.53%	-95.53%
Cash & Equivalents	$1.453M	$582.8K	$582.8K
Short-Term Investments
Other Short-Term Assets	$1.307M	$6.811M	$5.141M
YoY Change	-82.79%	112.83%	683.36%
Inventory	$12.99K	$465.6K	$465.6K
Prepaid Expenses
Receivables	$1.012M	$1.280M	$1.317M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.045M	$7.506M	$7.506M
YoY Change	-58.77%	-58.1%	-58.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.044M	$5.609M	$10.03M
YoY Change	48.11%	-18.0%	24.6%
Goodwill	$1.309M	$1.309M
YoY Change	0.0%	0.0%
Intangibles	$2.033M	$1.998M
YoY Change	-1.0%	-4.65%
Long-Term Investments	$4.325M	$4.300M	$4.300M
YoY Change	0.58%	13.16%	13.16%
Other Assets	$61.18K	$71.37K	$71.37K
YoY Change	-40.0%	-36.37%	-36.37%
Total Long-Term Assets	$19.40M	$19.05M	$19.05M
YoY Change	21.02%	11.99%	11.99%
TOTAL ASSETS
Total Short-Term Assets	$9.045M	$7.506M	$7.506M
Total Long-Term Assets	$19.40M	$19.05M	$19.05M
Total Assets	$28.44M	$26.56M	$26.56M
YoY Change	-25.08%	-23.96%	-23.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.702M	$3.147M	$4.010M
YoY Change	4.12%	-16.85%	-47.03%
Accrued Expenses	$415.8K	$418.6K	$418.6K
YoY Change	-9.92%	31.65%	31.65%
Deferred Revenue	$344.1K	$437.3K
YoY Change	-93.39%	-69.58%
Short-Term Debt	$5.396M	$2.648M	$2.648M
YoY Change	171.87%	11061.55%	34.3%
Long-Term Debt Due	$696.3K	$806.8K	$806.8K
YoY Change	3445.47%	4039.46%	4039.46%
Total Short-Term Liabilities	$12.56M	$8.326M	$8.326M
YoY Change	-4.51%	-28.14%	-28.14%
LONG-TERM LIABILITIES
Long-Term Debt	$1.555M	$1.671M	$1.671M
YoY Change	105.46%	119.38%	119.38%
Other Long-Term Liabilities	$2.005M	$2.119M	$2.119M
YoY Change	-17.18%	146.25%	146.25%
Total Long-Term Liabilities	$3.559M	$3.790M	$3.790M
YoY Change	12.03%	133.63%	133.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.56M	$8.326M	$8.326M
Total Long-Term Liabilities	$3.559M	$3.790M	$3.790M
Total Liabilities	$16.12M	$12.12M	$11.73M
YoY Change	-1.29%	-8.27%	-19.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$44.95M	-$41.43M
YoY Change	32.88%	25.13%
Common Stock	$143.0K	$126.1K
YoY Change	19.12%	5.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$49.68K	$49.68K
YoY Change
Treasury Stock Shares	23.12K shares	23.12K shares
Shareholders Equity	$12.75M	$14.82M	$14.82M
YoY Change
Total Liabilities & Shareholders Equity	$28.44M	$26.56M	$26.56M
YoY Change	-25.08%	-23.96%	-23.96%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$3.519M	-$3.733M	-$8.319M
YoY Change	390.74%	8.94%	-23.2%
Depreciation, Depletion And Amortization	$92.19K	$134.6K	$410.3K
YoY Change	-12.05%	-7.65%	2.9%
Cash From Operating Activities	-$1.379M	-$77.45K	-$5.631M
YoY Change	-142.33%	-120.95%	749.57%
INVESTING ACTIVITIES
Capital Expenditures	$531.1K	$831.7K	$2.760M
YoY Change	-42.45%	-228.16%	-42.79%
Acquisitions
YoY Change
Other Investing Activities	-$25.00K	$527.7K	-$1.025M
YoY Change	-95.83%	-197.95%	-74.19%
Cash From Investing Activities	-$638.3K	-$303.9K	-$3.853M
YoY Change	-65.7%	-74.41%	-59.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$49.68K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.887M	-1.154M	-$2.958M
YoY Change	-326.59%	-110.94%	-129.15%
NET CHANGE
Cash From Operating Activities	-$1.379M	-77.45K	-$5.631M
Cash From Investing Activities	-$638.3K	-303.9K	-$3.853M
Cash From Financing Activities	$2.887M	-1.154M	-$2.958M
Net Change In Cash	$869.7K	-1.535M	-$12.44M
YoY Change	612.67%	-115.77%	-88810.2%
FREE CASH FLOW
Cash From Operating Activities	-$1.379M	-$77.45K	-$5.631M
Capital Expenditures	$531.1K	$831.7K	$2.760M
Free Cash Flow	-$1.910M	-$909.1K	-$8.391M
YoY Change	-181.82%	-189.25%	52.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11986873	shares
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	us-gaap	Operating Loss Carryforwards Expiration Date OperatingLossCarryforwardsExpirationDate	2037-12-31
CY2022	us-gaap	Restricted Cash And Cash Equivalent Item Description RestrictedCashAndCashEquivalentItemDescription	The event that the Agreement was earlier terminated, CMC was entitled to receive the entire amount of such restricted stock that had vested as of such earlier termination date, but in no event less than 1,250 shares of such restricted stock. The Agreement also provided for customary indemnification and confidentiality obligations between the parties. The 2,500 shares of restricted stock of the Company's common stock has yet to be issued to CMC.
CY2022Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#FinanceLeaseLiability
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38037
CY2022	dei	Entity Registrant Name EntityRegistrantName	SAFE & GREEN HOLDINGS CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	990 Biscayne Blvd.,
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	#501,
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Office 12,
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33132
CY2022	dei	City Area Code CityAreaCode	(646)
CY2022	dei	Local Phone Number LocalPhoneNumber	240-4235
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2022	dei	Trading Symbol TradingSymbol	SGBX
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	19987535	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14314800	shares
CY2022	dei	Auditor Firm AuditorFirmId	726
CY2022	dei	Auditor Name AuditorName	Whitley Penn LLP
CY2022	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582776	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13024381	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1280456	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2917646	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	36384	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	41916	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4396826	usd
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	465560	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1273825	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	744211	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	656279	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7506213	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	17914047	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5608903	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6839943	usd
CY2022Q4	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	483546	usd
CY2021Q4	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	923172	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1309330	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1309330	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4421002	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1210053	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	857534	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	720137	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1997833	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2095232	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	71374	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	112159	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	700000	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	200000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3599945	usd
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3599945	usd
CY2022Q4	us-gaap	Assets Assets	26555680	usd
CY2021Q4	us-gaap	Assets Assets	34924018	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4009522	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7568851	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	437271	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1437579	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1225394	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	337469	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	264451	usd
CY2022Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	usd
CY2021Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	2648300	usd
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1971960	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8326282	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11586105	usd
CY2022Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	750000	usd
CY2021Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	750000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3039836	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	872124	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12116118	usd
CY2021Q4	us-gaap	Liabilities Liabilities	13208229	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12613978	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12590863	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11986873	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	126140	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	119869	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56173977	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53341405	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	23115	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	49680	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41428268	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33109220	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14822169	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20352054	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-382607	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1363735	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26555680	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34924018	usd
CY2021	us-gaap	Revenues Revenues	38341702	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	21139794	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	36012654	usd
CY2022	us-gaap	Gross Profit GrossProfit	3254152	usd
CY2021	us-gaap	Gross Profit GrossProfit	2329048	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5538352	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4186642	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4464836	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3788024	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	480934	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	288438	usd
CY2022	us-gaap	Other General Expense OtherGeneralExpense		usd
CY2021	us-gaap	Other General Expense OtherGeneralExpense	48794	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10484122	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	8311898	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-7229970	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-5982850	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	336239	usd
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1254	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	73821	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	57266	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	428411	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	62602	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-25265	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-44081	usd
CY2022	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee		usd
CY2021	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	-55	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	140728	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	74478	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7089242	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5908372	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7089242	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-5908372	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1229806	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4924302	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8319048	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10832674	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.16
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.16
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13332106	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13332106	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9339199	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9339199	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18437823	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1736531	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	707188	usd
CY2021	sgbx	Stock Issued During Period Issuance Of Common Stock Net Of Issuance Costs StockIssuedDuringPeriodIssuanceOfCommonStockNetOfIssuanceCosts	10487753	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3745134	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-5908372	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2838843	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-49680	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2976148	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7089242	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7089242	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-5908372	usd
CY2022	us-gaap	Depreciation Depreciation	410314	usd
CY2021	us-gaap	Depreciation Depreciation	398744	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	164092	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	165877	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	40785	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	40785	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	23726	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2022	sgbx	Accounts Receivable Write Offs AccountsReceivableWriteOffs	1073531	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2021	sgbx	Accounts Receivable Write Offs AccountsReceivableWriteOffs		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10526	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	167202	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	37397	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	37500	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2798844	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1647391	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-25265	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-44081	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-55	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-553132	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	449240	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-5532	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-1261220	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-808265	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	495681	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	87932	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	61778	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-691227	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-473331	usd
CY2022	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	-1139	usd
CY2021	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent		usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3519329	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3606889	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1000308	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-337161	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-264450	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-701110	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	176340	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-5000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-414674	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-472492	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5630614	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-662759	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2760032	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4824756	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	67832	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	42500	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	760	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	225000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	100000	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2022	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition		usd
CY2021	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	194969	usd
CY2022	sgbx	Payments For Project Development Costs PaymentsForProjectDevelopmentCosts	426194	usd
CY2021	sgbx	Payments For Project Development Costs PaymentsForProjectDevelopmentCosts	630470	usd
CY2022	sgbx	Payment On Security Deposit PaymentOnSecurityDeposit		usd
CY2021	sgbx	Payment On Security Deposit PaymentOnSecurityDeposit	203562	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	500000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	200000	usd
CY2022	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture		usd
CY2021	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	3600000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3853298	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9471257	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	10487753	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	707188	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	500000	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2000000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	51766	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	750000	usd
CY2022	sgbx	Finance Lease Payments FinanceLeasePayments	431865	usd
CY2021	sgbx	Finance Lease Payments FinanceLeasePayments		usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2976148	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3745134	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	49680	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2957693	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10148041	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12441605	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14025	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13024381	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13010356	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	582776	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13024381	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	271744	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	562	usd
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	3902175	usd
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred		usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582776	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6810672	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	6810762	usd
CY2022	sgbx	Working Capital WorkingCapital	-820000	usd
CY2022Q4	sgbx	Net Contract Liabilities On Uncompleted Contracts NetContractLiabilitiesOnUncompletedContracts	-400887	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	203926	usd
CY2022	sgbx	Accumulated Amortization Related To Deferred Costs AccumulatedAmortizationRelatedToDeferredCosts	132552	usd
CY2022	sgbx	Deferred Contract Costs Amortization Expense DeferredContractCostsAmortizationExpense	40785	usd
CY2021	sgbx	Deferred Contract Costs Amortization Expense DeferredContractCostsAmortizationExpense	40785	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', times; font-size: 10pt;"><div><div style="border-left: none; border-right: none;"><div style="border-left: none; border-right: none;"><div><div><p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="color: black;"><b><i>Accounting estimates<span style="line-height: inherit;"> </span></i></b>– The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgements and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period, together with amounts disclosed in the related notes to the financial statements. The Company's estimates used in these financial statements include, but are not limited to, revenue recognition, <span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;">stock-based compensation, accounts receivable reserves, inventory valuations, goodwill, the valuation allowance related to the Company’s deferred tax assets, the carrying amount of intangible assets, right of use assets and the recoverability and useful lives of long-lived assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</span> </span></span></p></div></div></div></div></div></div>
CY2022	sgbx	Warranty Offered On Completed Contracts WarrantyOfferedOnCompletedContracts	P1Y
CY2022	sgbx	Term Of Agreement TermOfAgreement	P2Y
CY2019Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.50	pure
CY2019Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	2500	shares
CY2021Q1	sgbx	Common Stock Vest And Be Issued Shares CommonStockVestAndBeIssuedShares	1250	shares
CY2021Q3	sgbx	Common Stock Remaining Vest And Be Issued Shares CommonStockRemainingVestAndBeIssuedShares	1250	shares
CY2022	sgbx	Gross Revenue Expected GrossRevenueExpected	0	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	11600000	usd
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	31400000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segments
CY2022	sgbx	Revenue At Point In Time RevenueAtPointInTime	11641727	usd
CY2022	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	12752219	usd
CY2021	sgbx	Revenue At Point In Time RevenueAtPointInTime	31548012	usd
CY2021	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	6793690	usd
CY2022	sgbx	Total Construction Revenue Segment TotalConstructionRevenueSegment	12752219	usd
CY2022Q4	sgbx	Total Construction Revenue Segment Percentage TotalConstructionRevenueSegmentPercentage	0.52	pure
CY2021	sgbx	Total Construction Revenue Segment TotalConstructionRevenueSegment	6793690	usd
CY2021Q4	sgbx	Total Construction Revenue Segment Percentage TotalConstructionRevenueSegmentPercentage	0.18	pure
CY2022	sgbx	Total Medical Revenue Segment TotalMedicalRevenueSegment	11641727	usd
CY2022Q4	sgbx	Total Medical Revenue Segment Percentage TotalMedicalRevenueSegmentPercentage	0.48	pure
CY2021	sgbx	Total Medical Revenue Segment TotalMedicalRevenueSegment	31548012	usd
CY2021Q4	sgbx	Total Medical Revenue Segment Percentage TotalMedicalRevenueSegmentPercentage	0.82	pure
CY2022	sgbx	Revenue From Contract With Segments Customer Excluding Assessed Tax RevenueFromContractWithSegmentsCustomerExcludingAssessedTax	24393946	usd
CY2022	sgbx	Revenue From Contract With Segments Customer Excluding Assessed Tax Percentage RevenueFromContractWithSegmentsCustomerExcludingAssessedTaxPercentage	1	pure
CY2021	sgbx	Revenue From Contract With Segments Customer Excluding Assessed Tax RevenueFromContractWithSegmentsCustomerExcludingAssessedTax	38341702	usd
CY2021	sgbx	Revenue From Contract With Segments Customer Excluding Assessed Tax Percentage RevenueFromContractWithSegmentsCustomerExcludingAssessedTaxPercentage	1	pure
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	306143	usd
CY2022Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	102217	usd
CY2022	sgbx	License Consideration Description LicenseConsiderationDescription	In consideration for the License, during the initial term, the Licensee agreed to pay the Company a royalty of (x) five percent (5%) on the first $20,000,000 of gross revenues derived from the Licensee’s commercialization of the License (net of customary discounts, sales taxes, delivery charges, and amounts for returns) (the “Gross Revenues”), (y) four and one-half percent (4.5%) on the next $30,000,000 of Gross Revenues, and (z) five percent (5%) on all Gross Revenues thereafter (collectively, the “Royalty”), subject to the following minimum royalty payments determined on a cumulative basis during the initial term: $500,000 in year 1, $750,000 in year 2, $1,500,000 in year 3, $2,000,000 in year 4, and $2,500,000 in year 5.
CY2022	sgbx	Redemption Distributions RedemptionDistributions	1250000	usd
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	200000	shares
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	502958	usd
CY2021	us-gaap	Other Income OtherIncome	60000	usd
CY2021Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	600000	usd
CY2022	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	350329	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582776	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13024381	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022	us-gaap	Bankruptcy Proceedings Description Of Proceedings BankruptcyProceedingsDescriptionOfProceedings	Intangible assets consist of $2,766,000 of proprietary knowledge and technology, which is being amortized over 20 years. In addition, included in intangible assets is $97,164 of trademarks, and $115,632 of website costs that are being amortized over 5 years.
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	980963	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	164092	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	815732	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	165877	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	174741	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	174035	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	170618	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	153283	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	149605	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1175551	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1997833	usd
CY2021Q2	sgbx	Project Development Costs ProjectDevelopmentCosts	820696	usd
CY2021Q2	sgbx	Project Development Costs Book Value ProjectDevelopmentCostsBookValue	4396826	usd
CY2021Q4	sgbx	Net Contract Liabilities On Uncompleted Contracts NetContractLiabilitiesOnUncompletedContracts	-1395663	usd
CY2022	sgbx	Legal Settlement Income Included In Other Income LegalSettlementIncomeIncludedInOtherIncome	150000	usd
CY2022	sgbx	Accounts Receivable From Lawsuit Settlement Written Off AccountsReceivableFromLawsuitSettlementWrittenOff	100000	usd
CY2022	sgbx	Accounts Payable Write Off AccountsPayableWriteOff	178000	usd
CY2022	sgbx	Accounts Payable Balance Settlement AccountsPayableBalanceSettlement	390000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; line-height: inherit;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account.</span></p><p style="margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </span></p><p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At December 31, 2022 and </span>2021<span style="font-family: 'times new roman', times; line-height: inherit;">, </span>80<span style="font-family: 'times new roman', times; line-height: inherit;">% and </span>78<span style="font-family: 'times new roman', times; line-height: inherit;">%, respectively, of the Company’s gross accounts receivable were due from </span>three<span style="font-family: 'times new roman', times; line-height: inherit;"> and four customers</span>.</span></p><p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </span></p><p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">Revenue in excess of<span style="line-height: inherit;"> </span></span>10<span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">% relating to<span style="line-height: inherit;"> </span></span>three<span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"> and<span style="line-height: inherit;"> one</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;"> </span>customers represented approximately<span style="line-height: inherit;">65</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">% and<span style="line-height: inherit;">80</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">% of the Company's total revenue for the year ended December 31, 2022 and 2021, respectively. </span></span></p><p style="margin: 0pt 0pt 0pt 36pt;"><br/></p><p style="margin: 0pt 0pt 0pt 36pt;"><span style="background-color: #ffffff; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; background-color: #ffffff; line-height: inherit;">For the year ending December 31, 2022 and 2021, there were no vendors that represented 10% or more of our cost of revenue.</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"> </span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span></p>
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1426202	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3880762	usd
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3431522	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	145746	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	795914	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1280456	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2917646	usd
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2635608	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	40580	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	0	usd
CY2021	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	167202	usd
CY2022Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	13730177	usd
CY2021Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	4272425	usd
CY2020Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	4572581	usd
CY2022Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
CY2021Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts	2238578	usd
CY2022Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	2160085	usd
CY2021Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	3156377	usd
CY2020Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-872302	usd
CY2022Q4	sgbx	Contract Receivables Retainage ContractReceivablesRetainage	11570092	usd
CY2021Q4	sgbx	Contract Receivables Retainage ContractReceivablesRetainage	3354626	usd
CY2020Q4	sgbx	Contract Receivables Retainage ContractReceivablesRetainage	5444883	usd
CY2022Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	11970979	usd
CY2021Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	4750289	usd
CY2020Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	5916487	usd
CY2020Q4	sgbx	Net Contract Liabilities On Uncompleted Contracts NetContractLiabilitiesOnUncompletedContracts	-471604	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	36384	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	41916	usd
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1303136	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	437271	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1437579	usd
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1774740	usd
CY2022Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-400887	usd
CY2021Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-1395663	usd
CY2020Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-471604	usd
CY2022Q4	sgbx	Project Development Costs Non Current ProjectDevelopmentCostsNonCurrent	289984	usd
CY2022Q4	sgbx	Security Deposits Non Current SecurityDepositsNonCurrent	193562	usd
CY2021Q4	sgbx	Project Development Costs Non Current ProjectDevelopmentCostsNonCurrent	719610	usd
CY2021Q4	sgbx	Security Deposits Non Current SecurityDepositsNonCurrent	203562	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6327629	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7249222	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	718726	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5608903	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6839943	usd
CY2022	us-gaap	Depreciation Depreciation	410314	usd
CY2021	us-gaap	Depreciation Depreciation	398744	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	37397	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	37500	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3147014	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3784662	usd
CY2022Q4	sgbx	Accrued Public Fees AccruedPublicFees	178491	usd
CY2021Q4	sgbx	Accrued Public Fees AccruedPublicFees	121749	usd
CY2022Q4	sgbx	Accrued Construction AccruedConstruction		usd
CY2021Q4	sgbx	Accrued Construction AccruedConstruction	367298	usd
CY2022Q4	sgbx	Accrued Losses AccruedLosses		usd
CY2021Q4	sgbx	Accrued Losses AccruedLosses	2238578	usd
CY2022Q4	sgbx	Accrued Medical AccruedMedical		usd
CY2021Q4	sgbx	Accrued Medical AccruedMedical	208512	usd
CY2022Q4	sgbx	Accrued General And Administrative AccruedGeneralAndAdministrative	254557	usd
CY2021Q4	sgbx	Accrued General And Administrative AccruedGeneralAndAdministrative	176432	usd
CY2022Q4	sgbx	Accrued Project Development Costs AccruedProjectDevelopmentCosts		usd
CY2021Q4	sgbx	Accrued Project Development Costs AccruedProjectDevelopmentCosts	77700	usd
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	349777	usd
CY2021Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	545003	usd
CY2022Q4	sgbx	Accrued Interest AccruedInterest	10923	usd
CY2021Q4	sgbx	Accrued Interest AccruedInterest	11333	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	68760	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	37584	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	4009522	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	7568851	usd
CY2021Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2000000	usd
CY2021Q3	sgbx	Net Loan Proceed NetLoanProceed	1948234	usd
CY2021Q3	us-gaap	Short Term Debt Terms ShortTermDebtTerms	The Short-Term Note has a term of one (1) year, provides for payments of interest only at a rate of twelve percent (12%) per annum and may be prepaid without penalty commencing nine (9) months after its issuance date.
CY2021Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.005	pure
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	20000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4134	usd
CY2021	sgbx	Short Term Debt Interest Charges ShortTermDebtInterestCharges	112348	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	23727	usd
CY2022Q3	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	500000	usd
CY2021Q4	sgbx	Value Of Renovation Improvements ValueOfRenovationImprovements	750000	usd
CY2021Q4	sgbx	Principal Amount Of Promissory Note PrincipalAmountOfPromissoryNote	750000	usd
CY2020Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	1059600	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2022	us-gaap	Lessor Direct Financing Lease Description LessorDirectFinancingLeaseDescription	The leases have remaining lease terms <span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', 'serif'; color: black;">ranging from one year to ten years.</span>
CY2022Q4	sgbx	Lease Liability Payments Due LeaseLiabilityPaymentsDue	4608275	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	285493	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	57552	usd
CY2022Q4	sgbx	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	343045	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2537577	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1727653	usd
CY2022Q4	sgbx	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	4265230	usd
CY2022	sgbx	Sublease Term SubleaseTerm	P1Y
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	770272	usd
CY2022Q4	sgbx	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	2517559	usd
CY2022Q4	sgbx	Operating Lease Liabilities Current OperatingLeaseLiabilitiesCurrent	-418619	usd
CY2022Q4	sgbx	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	-2118958	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2537577	usd
CY2022Q4	sgbx	Right Of Use Assets Finance Leases RightOfUseAssetsFinanceLeases	1903443	usd
CY2022Q4	sgbx	Lease Liability Current Maturities LeaseLiabilityCurrentMaturities	-806775	usd
CY2022Q4	sgbx	Lease Liability Non Current Liabilities LeaseLiabilityNonCurrentLiabilities	-920878	usd
CY2022Q4	sgbx	Total Finance Lease Liabilities TotalFinanceLeaseLiabilities	-1727653	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y11M4D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	525718	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	851792	usd
CY2022Q4	sgbx	Lease Liability Payments Due Next Twelve Months LeaseLiabilityPaymentsDueNextTwelveMonths	1377510	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	523722	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	801869	usd
CY2022Q4	sgbx	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	1325591	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	446349	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	131544	usd
CY2022Q4	sgbx	Lease Liability Payments Due Year Three LeaseLiabilityPaymentsDueYearThree	577893	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	207379	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2022Q4	sgbx	Lease Liability Payments Due Year Four LeaseLiabilityPaymentsDueYearFour	207379	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	211526	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		usd
CY2022Q4	sgbx	Lease Liability Payments Due Year Five LeaseLiabilityPaymentsDueYearFive	211526	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	908376	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2022Q4	sgbx	Lease Liability Payments Due After Year Five LeaseLiabilityPaymentsDueAfterYearFive	908376	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2823070	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1785205	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	367869	usd
CY2021Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	3217909	usd
CY2020Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	25117461	usd
CY2022	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	13803733	usd
CY2021	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	3191335	usd
CY2022	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	1086301	usd
CY2021	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	-18297197	usd
CY2022	sgbx	Construction Backlog Gross ConstructionBacklogGross	18107943	usd
CY2021	sgbx	Construction Backlog Gross ConstructionBacklogGross	10011599	usd
CY2022	sgbx	Contract Revenue ContractRevenue	11297181	usd
CY2021	sgbx	Contract Revenue ContractRevenue	6793690	usd
CY2022Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	6810762	usd
CY2021Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	3217909	usd
CY2021	sgbx	Contract Backlog Description ContractBacklogDescription	two contracts entered into during the third quarter of 2020 in the amount of approximately $4 million and approximately $2.95 million
CY2021Q1	sgbx	Number Of Large Contracts Cancelled Partially NumberOfLargeContractsCancelledPartially	1	pure
CY2021Q1	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	1300000	usd
CY2021Q3	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	pure
	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	870000	usd
CY2022Q4	sgbx	Number Of Large Contracts Cancelled Partially NumberOfLargeContractsCancelledPartially	1	pure
	sgbx	Cancellation Of Construction Backlog Contract Amountbacklogcontract CancellationOfConstructionBacklogContractAmountbacklogcontract	1300000	usd
CY2021Q3	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	pure
CY2021	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	780000	usd
CY2022Q4	sgbx	Number Of Large Contracts Cancelled Partially NumberOfLargeContractsCancelledPartially	1	pure
CY2021	sgbx	Cancellation Of Construction Backlog Contract Amountbacklogcontract CancellationOfConstructionBacklogContractAmountbacklogcontract	16900000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	6810762	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1600538	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2302762	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-688620	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-477375	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2289158	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2780137	usd
CY2022	sgbx	Provision Income Tax Expense Benefit ProvisionIncomeTaxExpenseBenefit	-2289158	usd
CY2021	sgbx	Provision Income Tax Expense Benefit ProvisionIncomeTaxExpenseBenefit	-2780137	usd
CY2022	sgbx	Amount Of Valuation Reserve AmountOfValuationReserve	-2289158	usd
CY2021	sgbx	Amount Of Valuation Reserve AmountOfValuationReserve	-2780137	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses		pure
CY2022	sgbx	Differences Attributable To Change In State Business Apportionment DifferencesAttributableToChangeInStateBusinessApportionment		pure
CY2021	sgbx	Differences Attributable To Change In State Business Apportionment DifferencesAttributableToChangeInStateBusinessApportionment		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.249	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.249	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8155944	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6480539	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	37734	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	239334	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2031628	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1231564	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-467395	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-488958	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-165336	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-131437	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	74801	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	47184	usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	213	usd
CY2021Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	205	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9667589	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7378431	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9667589	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7378431	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2289158	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2780137	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	18000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.80	pure
CY2022Q4	sgbx	Future Taxable Income Temporarily Removes Percentage FutureTaxableIncomeTemporarilyRemovesPercentage	0.80	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.50	pure
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2017Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	100
CY2017Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	176771	usd
CY2017Q3	sgbx	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	563	shares
CY2017Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	8321	shares
CY2019Q4	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	2117948	usd
CY2020Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	440000	shares
CY2020Q2	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	1522339	usd
CY2020Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	347661	usd
CY2020Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6000000	shares
CY2020Q2	sgbx	Options Granted To Purchase Common Stock OptionsGrantedToPurchaseCommonStock	900000	shares
CY2020Q2	sgbx	Common Stock Exercise Price Per Share CommonStockExercisePricePerShare	0.01
CY2020Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	900000	shares
CY2020Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6900000	shares
CY2020Q2	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	15596141	usd
CY2020Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1653859	usd
CY2020Q2	sgbx	Common Stock Number Of Shares Underwritter CommonStockNumberOfSharesUnderwritter	300000	shares
CY2021Q4	sgbx	Gross Proceeds GrossProceeds	11550000	usd
CY2019Q1	sgbx	Number Of Consultants NumberOfConsultants	1	consultants
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	Restricted stock units granted to Mr. Galvin, Mr. Armstrong, Mr. Shetty, and an aggregate of six employees and one consultant of 6,139, 772, 5,729 and an aggregate of 3,063, respectively, vest in installments over either a one-year, two-year, three-year and four-year period and will fully vest by the end of December 31, 2022. The fair value of these units upon issuance amounted to $847,957.
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	a total of 526 of restricted stock units were granted to two of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $58.80 and $55.20 per share, respectively, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date.
CY2021Q4	sgbx	Description Of Purchase Agreement DescriptionOfPurchaseAgreement	Pursuant to the terms of the Purchase Agreement, the Company issued to the investor (A) in a registered direct offering (i) 975,000 shares (the “Public Shares”) of its Common Stock, par value $0.01 per share (the “Common Stock”), and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 2,189,384 shares (the “Pre-Funded Warrant Shares”) of Common Stock and (B) in a concurrent private placement, Series A warrants to purchase up to 1,898,630 shares (the “Common Stock Warrant Shares”) of Common Stock (the “Common Stock Warrants,” and together with the Public Shares and the Pre-Funded Warrants, the “Securities”) (the “Offering The Pre-Funded Warrants were immediately exercisable at a nominal exercise price of $0.001 and all Pre-Funded Warrants sold have been exercised. The Common Stock Warrants have an exercise price of $4.80 per share, are exercisable upon issuance and will expire five years from the date of issuance. A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent for the transaction pursuant to that certain Placement Agency Agreement, dated as of October 25, 2021, by and between the Company and the Placement Agent (the “Placement Agency Agreement”), the Placement Agent received (i) a cash fee equal to seven percent (7.0%) of the gross proceeds from the placement of the Securities sold by the Placement Agent in the Offering and (ii) a non-accountable expense allowance of one half of one percent (0.5%) of the gross proceeds from the placement of the Gross Proceeds Securities sold by the Placement Agent in the Offering. The Company also reimbursed the Placement Agent’s expenses up to $50,000 upon closing the Offering.
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	10500000	usd
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	45000	shares
CY2019Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	17
CY2017Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-21
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-10-29
CY2019Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-08-29
CY2020Q2	sgbx	Warrants To Purchase WarrantsToPurchase	300000	shares
CY2020Q2	us-gaap	Share Price SharePrice	3.14
CY2020Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-05-05
CY2021Q4	sgbx	Warrants To Purchase WarrantsToPurchase	1898630	shares
CY2021Q4	us-gaap	Share Price SharePrice	4.8
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2016Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	25000	shares
CY2016Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3625000	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	376060	shares
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2798844	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1647391	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2798844	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1647391	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2021	sgbx	Allocated Share Based Compensation Expense Accrued AllocatedShareBasedCompensationExpenseAccrued	2666	usd
CY2022Q4	us-gaap	Share Price SharePrice	1.28
CY2019Q1	sgbx	Number Of Employees NumberOfEmployees	6	employee
CY2019Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	9189	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.4
CY2022	sgbx	Options Vested Description OptionsVestedDescription	the Company’s common stock for the ten trading days immediately preceding and including the grant date. Restricted stock units granted to directors on June 5, 2019 vest on the earlier of (A) the first anniversary of the date of the grant or (B) the date of the annual meeting of the Company’s stockholders that occurs in the year immediately following the date of the grant; and are payable six months after the termination of the director from the Board or death or disability.
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	425000	shares
CY2020Q3	sgbx	Number Of Consultants NumberOfConsultants	1	consultants
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.81
CY2020Q3	sgbx	Options Vested Description OptionsVestedDescription	the Company's common stock on September 23, 2020. Restricted stock units granted to Mr. Armstrong, Mr. Sheeran, and an aggregate of seven employees and one consultant of 50,000, 75,000 and an aggregate of 300,000, respectively, and 1/3 will vest on September 23, 2020, 1/3 on the one year anniversary of the grant date and 1/3 on the two year anniversary of the grant date. The fair value of these units upon issuance amounted to $769,250.
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1214500	shares
CY2021Q4	us-gaap	Share Price SharePrice	3.38
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	475000	shares
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1686599	usd
CY2019Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2100000	usd
CY2018Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	761401.66	usd
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2861401.66	usd

Files In Submission

Name	View Source	Status
0001213900-23-024927-index-headers.html	Edgar Link	pending
0001213900-23-024927-index.html	Edgar Link	pending
0001213900-23-024927.txt	Edgar Link	pending
0001213900-23-024927-xbrl.zip	Edgar Link	pending
ex211_2.htm	Edgar Link	pending
ex231_3.htm	Edgar Link	pending
ex311_4.htm	Edgar Link	pending
ex312_5.htm	Edgar Link	pending
ex321_6.htm	Edgar Link	pending
ex49_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20221231.htm	Edgar Link	pending
sgbx-20221231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sgbx-20221231_lab.xml	Edgar Link	unprocessable
sgbx-20221231_cal.xml	Edgar Link	unprocessable
sgbx-20221231_def.xml	Edgar Link	unprocessable
sgbx-20221231_pre.xml	Edgar Link	unprocessable
sgbx-20221231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2023 Q1 Form 10-K Financial Statement

#000121390023024927 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2023 Q1 Form 10-K Financial Statement

#000121390023024927 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx